Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A LARGE-SCALE CLUSTER RANDOMIZED TRIAL TO DETERMINE THE EFFECTS OF SODIUM REDUCTION ON STROKE: THE CHINA SALT SUBSTITUTE AND STROKE STUDY (SSaSS)

NCT02092090 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT02092090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02092090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A LARGE-SCALE CLUSTER RANDOMIZED TRIAL TO DETERMINE THE EFFECTS OF SODIUM REDUCTION ON STROKE: THE CHINA SALT SUBSTITUTE AND STROKE STUDY (SSaSS)
Lead sponsor
The George Institute
Phase
Not applicable
Overall status
Completed
Start date
July 9, 2014
Completion date
September 4, 2020
Enrollment
20,996 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stroke